PGL prospa group limited.
Add to My Watchlist 0.00% ! 44.5¢

drug pi-88, melanoma; how good is it?, page-2

  1. stolwyk
    22,691 Posts.
    clock Created with Sketch.
    27/02/04
    14:28
    Post #: 398039
    But there is still more:

    Febr. 11, 2004: "Today marks the beginning of a 90 patient, multicenter Phase II trial of PI-88 in combination with Taxotere® for the second-line treatment of advanced non-small cell lung cancer (NSCLC)".

    So, Phase II Myeloma has been completed and currently there are 2 more Phase II trials going: Melanoma and NSCLC.

    Gerry
    PGL Price at posting: 0.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Significant new gold-copper discovery at Minyari Dome delivers high-grade results
right-arrow Created with Sketch.
NEWS Proteomics International granted first patent for endometriosis diagnostic blood test in Japan
right-arrow Created with Sketch.
NEWS High-Grade Niobium Intercept Delivered by Initial Drilling at Joyce
right-arrow Created with Sketch.
ACW Actinogen Confirms 100th Participant in Alzheimer’s Disease Trial and Interim Analysis Timeline
right-arrow Created with Sketch.
NEWS Outstanding Drill Results Define New High-Grade Iris Zone at Apollo Hill
right-arrow Created with Sketch.
NEWS Next Science to Sell Majority of Assets in Proposed Transaction
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.